SG Americas Securities LLC Purchases 50,629 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

SG Americas Securities LLC increased its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 732.5% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 57,541 shares of the company's stock after acquiring an additional 50,629 shares during the period. SG Americas Securities LLC's holdings in Privia Health Group were worth $1,048,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Benjamin F. Edwards & Company Inc. lifted its holdings in Privia Health Group by 8.5% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 7,695 shares of the company's stock valued at $134,000 after purchasing an additional 605 shares during the last quarter. Arizona State Retirement System raised its stake in shares of Privia Health Group by 2.4% in the second quarter. Arizona State Retirement System now owns 26,574 shares of the company's stock worth $462,000 after acquiring an additional 617 shares during the last quarter. Signaturefd LLC raised its stake in shares of Privia Health Group by 46.3% in the second quarter. Signaturefd LLC now owns 1,978 shares of the company's stock worth $34,000 after acquiring an additional 626 shares during the last quarter. Allspring Global Investments Holdings LLC raised its stake in shares of Privia Health Group by 9.2% in the first quarter. Allspring Global Investments Holdings LLC now owns 8,970 shares of the company's stock worth $176,000 after acquiring an additional 756 shares during the last quarter. Finally, Parkside Financial Bank & Trust raised its stake in shares of Privia Health Group by 9.7% in the second quarter. Parkside Financial Bank & Trust now owns 8,684 shares of the company's stock worth $151,000 after acquiring an additional 771 shares during the last quarter. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Privia Health Group Stock Performance

Shares of PRVA traded up $0.43 during mid-day trading on Friday, reaching $17.55. The company had a trading volume of 1,216,851 shares, compared to its average volume of 864,850. The company's 50 day simple moving average is $18.94 and its 200 day simple moving average is $18.36. Privia Health Group, Inc. has a 1-year low of $15.92 and a 1-year high of $24.35. The company has a market capitalization of $2.09 billion, a price-to-earnings ratio of 114.13, a P/E/G ratio of 3.93 and a beta of 0.76.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last issued its quarterly earnings data on Thursday, August 8th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.05 by ($0.02). The business had revenue of $422.30 million during the quarter, compared to the consensus estimate of $411.50 million. Privia Health Group had a net margin of 0.88% and a return on equity of 2.42%. The firm's quarterly revenue was up 2.2% compared to the same quarter last year. During the same quarter last year, the business earned $0.06 EPS. As a group, equities analysts forecast that Privia Health Group, Inc. will post 0.16 earnings per share for the current fiscal year.

Insider Activity at Privia Health Group

In related news, CEO Parth Mehrotra sold 135,142 shares of the firm's stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total value of $2,500,127.00. Following the completion of the transaction, the chief executive officer now owns 247,771 shares in the company, valued at $4,583,763.50. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 14.20% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of equities analysts have weighed in on PRVA shares. KeyCorp started coverage on shares of Privia Health Group in a research note on Friday. They issued an "overweight" rating and a $23.00 target price for the company. Royal Bank of Canada reissued an "outperform" rating and set a $28.00 price target on shares of Privia Health Group in a research note on Wednesday, August 14th. Robert W. Baird boosted their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an "outperform" rating in a research note on Monday, August 26th. Finally, Evercore ISI dropped their price target on shares of Privia Health Group from $23.00 to $20.00 and set an "outperform" rating for the company in a research note on Tuesday, July 9th. Two research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $24.73.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.